Abstract
The osmotic tolerance of rabbit corneal endothelial cultures was determined for a balanced salt solution and various pharmaceutical vehicles in an effort to determine the biocompatibility of the different formulations after 4-128 min exposures. Acute change was assessed by monitoring the release of radiolabeled nucleotides and corresponding changes in tissue morphology of the prelabeled cultures. Protracted damage was evaluated by re-examining the morphology of the same cultures after 24 hr along with quantitative measurements of residual 3H release, tissue loss, and concomitant changes in protein synthesis. Our testing results indicated that the permissive limit of a balanced salt solution was between 200 and 400 mOsm, which is comparable to the guidelines for native endothelium in situ established by organ perfusion studies. In contrast, the permissive limits for prototypes of intraocular vehicles were more restricted, since only isotonic formulations were relatively nontoxic. Topical vehicles, by comparison, were much more damaging, which probably contraindicates their intraocular usage. These data indicate that this type of bioassay can be used effectively for screening and drug development programs, and for establishing accurate guidelines for pharmaceutical formulations.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 31-46 |
| Number of pages | 16 |
| Journal | Cutaneous and Ocular Toxicology |
| Volume | 11 |
| Issue number | 1 |
| DOIs | |
| State | Published - 1992 |
Fingerprint
ASJC Scopus subject areas
- Toxicology
- Health, Toxicology and Mutagenesis
- Ophthalmology
Cite this
Osmotic tolerance of rabbit corneal endothelium in tissue culture. / Meyer, Dale R.; McCulley, James P.
In: Cutaneous and Ocular Toxicology, Vol. 11, No. 1, 1992, p. 31-46.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Osmotic tolerance of rabbit corneal endothelium in tissue culture
AU - Meyer, Dale R.
AU - McCulley, James P
PY - 1992
Y1 - 1992
N2 - The osmotic tolerance of rabbit corneal endothelial cultures was determined for a balanced salt solution and various pharmaceutical vehicles in an effort to determine the biocompatibility of the different formulations after 4-128 min exposures. Acute change was assessed by monitoring the release of radiolabeled nucleotides and corresponding changes in tissue morphology of the prelabeled cultures. Protracted damage was evaluated by re-examining the morphology of the same cultures after 24 hr along with quantitative measurements of residual 3H release, tissue loss, and concomitant changes in protein synthesis. Our testing results indicated that the permissive limit of a balanced salt solution was between 200 and 400 mOsm, which is comparable to the guidelines for native endothelium in situ established by organ perfusion studies. In contrast, the permissive limits for prototypes of intraocular vehicles were more restricted, since only isotonic formulations were relatively nontoxic. Topical vehicles, by comparison, were much more damaging, which probably contraindicates their intraocular usage. These data indicate that this type of bioassay can be used effectively for screening and drug development programs, and for establishing accurate guidelines for pharmaceutical formulations.
AB - The osmotic tolerance of rabbit corneal endothelial cultures was determined for a balanced salt solution and various pharmaceutical vehicles in an effort to determine the biocompatibility of the different formulations after 4-128 min exposures. Acute change was assessed by monitoring the release of radiolabeled nucleotides and corresponding changes in tissue morphology of the prelabeled cultures. Protracted damage was evaluated by re-examining the morphology of the same cultures after 24 hr along with quantitative measurements of residual 3H release, tissue loss, and concomitant changes in protein synthesis. Our testing results indicated that the permissive limit of a balanced salt solution was between 200 and 400 mOsm, which is comparable to the guidelines for native endothelium in situ established by organ perfusion studies. In contrast, the permissive limits for prototypes of intraocular vehicles were more restricted, since only isotonic formulations were relatively nontoxic. Topical vehicles, by comparison, were much more damaging, which probably contraindicates their intraocular usage. These data indicate that this type of bioassay can be used effectively for screening and drug development programs, and for establishing accurate guidelines for pharmaceutical formulations.
UR - http://www.scopus.com/inward/record.url?scp=0026509787&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026509787&partnerID=8YFLogxK
U2 - 10.3109/15569529209042591
DO - 10.3109/15569529209042591
M3 - Article
AN - SCOPUS:0026509787
VL - 11
SP - 31
EP - 46
JO - Cutaneous and Ocular Toxicology
JF - Cutaneous and Ocular Toxicology
SN - 1556-9527
IS - 1
ER -